Related Experiment Videos
Surfactant replacement therapy. Innovative care for the premature infant
1Temple University Health Sciences Center, Neonatal Intensive Care Unit, Philadelphia, PA 19140.
Insights
Surfactant replacement therapy offers a promising treatment for premature infants suffering from hyaline membrane disease. Specialized nursing care is crucial for optimizing outcomes in these vulnerable newborns.
Area of Science:
- Neonatal care
- Pulmonology
- Pediatric intensive care
Background:
- Prematurity presents significant challenges in perinatal care.
- Hyaline membrane disease in premature infants is primarily caused by surfactant deficiency.
- Surfactant replacement therapy has emerged as a key intervention.
Purpose of the Study:
- To review the history and current status of surfactant replacement therapy.
- To outline essential nursing care for infants receiving this treatment.
- To identify future research directions in neonatal nursing.
Main Methods:
- Review of historical data on surfactant therapy.
- Analysis of current clinical trials.
- Discussion of nursing interventions in delivery and NICU settings.
Main Results:
- Surfactant replacement therapy is a promising treatment for premature infants with hyaline membrane disease.
- Specialized nursing care is vital for successful treatment outcomes.
- Specific nursing interventions are required during delivery and in the neonatal intensive care unit.
Conclusions:
- Surfactant replacement therapy represents a significant advancement in managing hyaline membrane disease in premature infants.
- Optimizing patient outcomes necessitates tailored nursing care strategies.
- Further nursing research is needed to refine and advance this therapeutic approach.
Abstract:
Prematurity is one of the most perplexing problems in perinatal care. Since the discovery of a surfactant deficiency as the primary etiology of hyaline membrane disease, attempts have been made to supplement surfactant in the premature infant. Surfactant replacement therapy is a promising new treatment for the premature infant with hyaline membrane disease. The history of surfactant replacement therapy, current trials of this therapy, nursing care of the infant receiving surfactant replacement, and future directions for nursing research in this area are discussed. Infants receiving this therapy require special nursing care to assure the best possible outcome. Nursing interventions at the time of delivery as well as those required in the neonatal intensive care unit are discussed.